In this special episode of the View, Dr. Peter Block and Dr. Deepak Bhatt discuss highlights from Day 1 of AHA.19, including the Dapagliflozin and Prevention of Adverse-Outcomes in HF Trial (DAPA-HF), the Colchicine Cardiovascular Outcomes Trial (COLCOT), and the International Study Of Comparative Health Effectiveness With Medical And Invasive Approaches (ISCHEMIA) trials.

Subscribe on iTunes | Subscribe on Google Play

Keywords: AHA Annual Scientific Sessions, AHA19, EaglesEyeView, Dyslipidemias, Heart Failure, Acute Coronary Syndrome, Angina, Unstable, Colchicine, Diarrhea, Heart Arrest, Inflammation, Myocardial Infarction, Myocardial Revascularization, Percutaneous Coronary Intervention, Primary Prevention, Stroke, Benzhydryl Compounds, Glomerular Filtration Rate, Glucosides, Heart Failure, Hospitalization, Hypotension, Natriuretic Peptide, Brain, Peptide Fragments, Renal Insufficiency, Sodium-Glucose Transporter 2, Stroke Volume

< Back to Listings